Table 2 Demographic characteristics of Congolese participants immunized with SARS-CoV-2 vaccines BBIP-CorV or Ad26.COV2.S
Variables | Vaccinated | Unvaccinated N = 50 | ||
|---|---|---|---|---|
BBIP-CorV N = 24 | Janssen/Ad26.COV2.S N = 26 | P-value | ||
Age (years) (IQR) | 45 (34.25; 56) | 34.50 (26; 49.75) | 38 (27.75; 47) | |
Gender n (%) | ||||
Female | 10(41.7) | 14(63.9) | 0.412 | 22 (44) |
Male | 14(58.3) | 12(46.1) | 28 (56) | |
IgG results n (%) | ||||
Negative | 5(20.8) | 3(11.6) | 29 (58) | |
Positive | 19(79.2) | 23(88.4) | 0.456 | 21 (42) |
Median IgG concentration (UI/ml) (IQR) | 115 (50.14; 318.1) | 550.9 (74.31; 1085) | 0.014 | 58.81 (38.07; 160.1) |
Neutralizing antibody results n (%) | ||||
Negative | 7(29.2) | 6(23) | 0.750 | 23 (46) |
Positive | 17(70.8) | 20(77) | 0.431 | 27 (54) |
Median %inhibition (IQR) | 62.23 (14.01; 91.51) | 87.81 (30.65; 91.14) | 0.912 | 30.75 (4.61; 73.82) |